CDMS Applied: Bridging Molecular Complexity and Clarity from Bioconjugates to Viruses
Join us to see how CDMS extends the reach of mass spectrometry - turning molecular complexity into actionable insight.
As biomolecular systems grow larger and more heterogeneous, conventional MS reaches its limits. Charge detection mass spectrometry (CDMS) overcomes these challenges by directly measuring the mass of individual ions. In this webinar, two experts show how CDMS enables accurate characterization of complex systems in biopharma and structural virology. Dr. Andi Flütsch (Johnson & Johnson) examines heterogeneous glycoprotein vaccines, while Prof. Charlotte Uetrecht (University of Lübeck, CSSB) reveals viral capsid heterogeneity and assembly using norovirus.
Why you should attend
- Understand why CDMS matters for analyzing highly heterogeneous, high mass biomolecules beyond the limits of conventional native MS.
- See how CDMS solves real biopharma challenges, enabling characterization and comparability of complex glycoprotein vaccines where traditional analytics fall short.
- Gain new insight into viral heterogeneity, learning how CDMS reveals mass, stoichiometry, and assembly features inaccessible with native MS alone.
Who should attend
- Scientists and engineers working with complex molecular or particulate systems across chemistry, biology, biopharma, materials, and nanoscience
- Analytical and structural science leaders looking to push beyond the limits of conventional mass spectrometry for heterogeneous, high mass samples
- R&D managers and decision makers evaluating next generation analytical technologies to enable deeper insight and more confident decisions
Speaker: Charlotte Uetrecht (Professor/Scientific Director, University of Lübeck/Centre for Structural System Biology (CSSB))
Professor Charlotte Uetrecht has been Full Professor of Chemistry at the University of Lübeck since 2024, co director of the Institute of Chemistry and Metabolomics, and Scientific Director of the Centre for Structural Systems Biology (CSSB) since 2026. She leads the Dynamics of Viral Structures group, focusing on large viral protein complexes using native mass spectrometry and complementary structural methods, with emphasis on coronaviruses and norovirus particles. She earned her Ph.D. from Utrecht University under Prof. Albert J.R. Heck.
Speaker: Andi Flütsch (Associate Director, Analytical & Process Development, Johnson & Johnson Innovative Medicine)
Dr. Flütsch is an Associate Director in Analytical & Process Development at Johnson & Johnson Innovative Medicine based in Switzerland. He has extensive experience in analytical development and protein characterization, supporting products from late-stage development through commercialization. His work focuses on advanced analytical technologies and GMP‑ready analytical strategies for complex modalities such as glycoproteins and viral vectors. Dr. Flütsch received Ph.D. from University of Zurich in 2013 in Biochemistry and Molecular Biology.
